Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Genomic Health Inc (GHDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,004,483
  • Shares Outstanding, K 37,072
  • Annual Sales, $ 394,110 K
  • Annual Income, $ 25,680 K
  • 60-Month Beta 0.88
  • Price/Sales 5.00
  • Price/Cash Flow 36.69
  • Price/Book 6.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.34
  • Number of Estimates 6
  • High Estimate 0.40
  • Low Estimate 0.32
  • Prior Year 0.26
  • Growth Rate Est. (year over year) +30.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.82 +2.37%
on 05/23/19
67.94 -20.42%
on 05/06/19
-11.05 (-16.97%)
since 04/24/19
3-Month
52.82 +2.37%
on 05/23/19
82.10 -34.14%
on 02/25/19
-27.40 (-33.63%)
since 02/22/19
52-Week
36.94 +46.37%
on 05/25/18
92.18 -41.34%
on 11/07/18
+15.69 (+40.88%)
since 05/24/18

Most Recent Stories

More News
Genomic Health I Falls 2.19% on Heavy Volume: Watch For Potential Rebound

Genomic Health I (NASDAQ:GHDX) traded in a range yesterday that spanned from a low of $55.00 to a high of $55.92. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of...

GHDX : 54.07 (+1.65%)
Genomic Health I Has Returned 22.1% Since SmarTrend Recommendation (GHDX)

SmarTrend identified a Downtrend for Genomic Health I (NASDAQ:GHDX) on March 6th, 2019 at $75.16. In approximately 2 months, Genomic Health I has returned 22.13% as of today's recent price of $58.53.

GHDX : 54.07 (+1.65%)
Look for Shares of Genomic Health I to Potentially Rebound after Yesterday's 11.84% Sell Off

Genomic Health I (NASDAQ:GHDX) traded in a range yesterday that spanned from a low of $57.71 to a high of $58.74. Yesterday, the shares fell 11.8%, which took the trading range below the 3-day low of...

GHDX : 54.07 (+1.65%)
Genomic Health (GHDX) Q1 Earnings Top Estimates, Margins Up

Genomic Health (GHDX) registers strong year-over-year growth in revenues on solid domestic and overseas performances.

SYK : 184.77 (+0.15%)
GHDX : 54.07 (+1.65%)
XRAY : 53.75 (+0.02%)
CNMD : 81.43 (+0.54%)
Genomic Health (GHDX) Q1 Earnings and Revenues Top Estimates

Genomic Health (GHDX) delivered earnings and revenue surprises of 17.24% and 1.58%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

GHDX : 54.07 (+1.65%)
Genomic Health: 1Q Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Genomic Health Inc. (GHDX) on Tuesday reported first-quarter net income of $13 million, after reporting a loss in the same period a year earlier.

GHDX : 54.07 (+1.65%)
Genomic Health Reports First Quarter 2019 Financial Results and Recent Business Progress

Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended March 31, 2019.

GHDX : 54.07 (+1.65%)
Genomic Health to Announce First Quarter 2019 Financial Results and Host Conference Call on Tuesday, May 7, 2019

Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 7 at 4:30 p.m. Eastern Time to discuss its first quarter 2019 financial results....

GHDX : 54.07 (+1.65%)
3 Medical Product Stocks Set to Beat This Earnings Season

The global medical device space takes significant strides in terms of research and development (R&D) and regulatory progress in the first quarter.

ACB : 8.31 (+0.73%)
GHDX : 54.07 (+1.65%)
ILMN : 312.45 (+1.13%)
MYGN : 24.49 (+1.45%)
NSTG : 27.76 (+3.35%)
ISRG : 476.53 (+0.58%)
PRGO : 47.35 (-0.88%)
Future Demand Of Prostate Cancer Diagnostics Market Are Growing Rapidly In Industry MDxHealth, 3D Signatures, Genomic Health, Abbott, OPKO Health, INC., Siemens Healthcare GmbH

The is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of disease requiring surgical treatment, Increasing prevalence of Cancer and Hernia and growing...

MXDHF : 1.5000 (-6.25%)
SIEGY : 59.1600 (+2.04%)
GHDX : 54.07 (+1.65%)
DXD.VN : 0.040 (unch)
OPK : 1.96 (+2.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade GHDX with:

Business Summary

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict...

See More

Key Turning Points

2nd Resistance Point 55.24
1st Resistance Point 54.65
Last Price 54.07
1st Support Level 53.45
2nd Support Level 52.84

See More

52-Week High 92.18
Fibonacci 61.8% 71.08
Fibonacci 50% 64.56
Fibonacci 38.2% 58.04
Last Price 54.07
52-Week Low 36.94

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar